Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Common stock	Additional paid-in capital	Additional paid-in capital Cumulative Effect, Period of Adoption, Adjustment	Accumulated deficit	Accumulated deficit Cumulative Effect, Period of Adoption, Adjustment	Accumulated other comprehensive income (loss)
Beginning balance (in shares) at Dec. 31, 2020			73,874,904
Beginning balance at Dec. 31, 2020	$ 320,684		$ 8	$ 897,607		$ (577,530)		$ 599
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accounting Standards Update [Extensible Enumeration]	Accounting Standards Update 2020-06 [Member]
Vesting of restricted stock (in shares)			906,037
Exercise of stock options (in shares)	325,494		325,494
Exercise of stock options	$ 2,014			2,014
Stock-based compensation	32,008			32,008
Issuance of common stock pursuant to Employee Stock Purchase Plan (in shares)			160,790
Issuance of common stock pursuant to Employee Stock Purchase Plan	1,315			1,315
Issuance of common stock for restricted stock units vested (in shares)			485,439
Net loss	(234,004)					(234,004)
Other comprehensive income (loss)	(554)							(554)
Ending balance (in shares) at Dec. 31, 2021			75,752,664
Ending balance at Dec. 31, 2021	121,463	$ (44,838)	$ 8	932,944	$ (53,527)	(811,534)	$ 8,689	45
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock (in shares)			16,649,365
Issuance of common stock	$ 119,946		$ 2	119,944
Vesting of restricted stock (in shares)			662,700
Exercise of stock options (in shares)	270,707		270,707
Exercise of stock options	$ 1,736			1,736
Stock-based compensation	42,553			42,553
Issuance of common stock pursuant to Employee Stock Purchase Plan (in shares)			157,858
Issuance of common stock pursuant to Employee Stock Purchase Plan	1,214			1,214
Issuance of common stock for restricted stock units vested (in shares)			929,887
Net loss	(229,378)					(229,378)
Other comprehensive income (loss)	$ (619)							(619)
Ending balance (in shares) at Dec. 31, 2022	94,423,181		94,423,181
Ending balance at Dec. 31, 2022	$ 12,077		$ 10	1,044,864		(1,032,223)		(574)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock (in shares)			129,869,440
Issuance of common stock	$ 201,323		$ 13	201,310
Vesting of restricted stock (in shares)			55,225
Exercise of stock options (in shares)	0
Stock-based compensation	$ 28,518			28,518
Issuance of common stock pursuant to Employee Stock Purchase Plan (in shares)			336,795
Issuance of common stock pursuant to Employee Stock Purchase Plan	444			444
Issuance of common stock for restricted stock units vested (in shares)			724,674
Net loss	(179,817)					(179,817)
Other comprehensive income (loss)	$ 224							224
Ending balance (in shares) at Dec. 31, 2023	225,409,315		225,409,315
Ending balance at Dec. 31, 2023	$ 62,769		$ 23	$ 1,275,136		$ (1,212,040)		$ (350)